Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents

Schizophrenia is a chronic mental illness, which remains difficult to treat. A high resistance to the available therapies, their insufficient efficacy, and numerous side effects are the reasons why there is an urgent need to develop new antipsychotics. This study aimed to assess the antipsychotic-li...

Full description

Bibliographic Details
Main Authors: Elżbieta Żmudzka, Klaudia Lustyk, Monika Głuch-Lutwin, Barbara Mordyl, Alicja Zakrzewska-Sito, Paweł Mierzejewski, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/24/15929
_version_ 1797431462708903936
author Elżbieta Żmudzka
Klaudia Lustyk
Monika Głuch-Lutwin
Barbara Mordyl
Alicja Zakrzewska-Sito
Paweł Mierzejewski
Jolanta Jaśkowska
Marcin Kołaczkowski
Jacek Sapa
Karolina Pytka
author_facet Elżbieta Żmudzka
Klaudia Lustyk
Monika Głuch-Lutwin
Barbara Mordyl
Alicja Zakrzewska-Sito
Paweł Mierzejewski
Jolanta Jaśkowska
Marcin Kołaczkowski
Jacek Sapa
Karolina Pytka
author_sort Elżbieta Żmudzka
collection DOAJ
description Schizophrenia is a chronic mental illness, which remains difficult to treat. A high resistance to the available therapies, their insufficient efficacy, and numerous side effects are the reasons why there is an urgent need to develop new antipsychotics. This study aimed to assess the antipsychotic-like effects of JJGW08, a novel arylpiperazine alkyl derivative of salicylamide, in rodents. First, considering the JJGW08 receptor profile, we investigated the compound’s intrinsic activity towards dopamine D<sub>2</sub> and serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>7</sub> receptors using functional assays. Next, we assessed the effect of JJGW08 on MK-801- and amphetamine-induced hyperlocomotion, its risk of inducing catalepsy and impairing motor coordination, as well as the anxiolytic-like effects in the four-plate and marble burying tests in mice. Finally, we investigated the antipsychotic-like properties of JJGW08 in rats using MK-801-induced hyperlocomotion and prepulse inhibition tests. We found that JJGW08 showed antagonistic properties at dopamine D<sub>2</sub> and serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>7</sub> receptors. However, the effect on the 5-HT<sub>2A</sub> and 5-HT<sub>7</sub> receptors was very weak. Moreover, the tested compound showed an antipsychotic-like effect in MK-801- and amphetamine-induced hyperlocomotion but not in a prepulse inhibition test in rats. Notably, JJGW08 demonstrated anxiolytic-like properties in both behavioral tests. Importantly, the compound did not induce catalepsy or motor coordination impairment in mice at antipsychotic-like doses. Our study suggests it is worth searching for new potential antipsychotics among arylpiperazine alkyl derivatives of salicylamide.
first_indexed 2024-03-09T09:45:26Z
format Article
id doaj.art-0b286050b9a844048be66d18514d16f1
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T09:45:26Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-0b286050b9a844048be66d18514d16f12023-12-02T00:36:46ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-12-0123241592910.3390/ijms232415929Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in RodentsElżbieta Żmudzka0Klaudia Lustyk1Monika Głuch-Lutwin2Barbara Mordyl3Alicja Zakrzewska-Sito4Paweł Mierzejewski5Jolanta Jaśkowska6Marcin Kołaczkowski7Jacek Sapa8Karolina Pytka9Department of Social Pharmacy, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, PolandDepartment of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, PolandDepartment of Pharmacobiology, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, PolandDepartment of Pharmacobiology, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, PolandDepartment of Pharmacology, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957 Warszawa, PolandDepartment of Pharmacology, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957 Warszawa, PolandDepartment of Organic Chemistry and Technology, Faculty of Chemical and Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, PolandDepartment of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, PolandDepartment of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, PolandDepartment of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, PolandSchizophrenia is a chronic mental illness, which remains difficult to treat. A high resistance to the available therapies, their insufficient efficacy, and numerous side effects are the reasons why there is an urgent need to develop new antipsychotics. This study aimed to assess the antipsychotic-like effects of JJGW08, a novel arylpiperazine alkyl derivative of salicylamide, in rodents. First, considering the JJGW08 receptor profile, we investigated the compound’s intrinsic activity towards dopamine D<sub>2</sub> and serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>7</sub> receptors using functional assays. Next, we assessed the effect of JJGW08 on MK-801- and amphetamine-induced hyperlocomotion, its risk of inducing catalepsy and impairing motor coordination, as well as the anxiolytic-like effects in the four-plate and marble burying tests in mice. Finally, we investigated the antipsychotic-like properties of JJGW08 in rats using MK-801-induced hyperlocomotion and prepulse inhibition tests. We found that JJGW08 showed antagonistic properties at dopamine D<sub>2</sub> and serotonin 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>7</sub> receptors. However, the effect on the 5-HT<sub>2A</sub> and 5-HT<sub>7</sub> receptors was very weak. Moreover, the tested compound showed an antipsychotic-like effect in MK-801- and amphetamine-induced hyperlocomotion but not in a prepulse inhibition test in rats. Notably, JJGW08 demonstrated anxiolytic-like properties in both behavioral tests. Importantly, the compound did not induce catalepsy or motor coordination impairment in mice at antipsychotic-like doses. Our study suggests it is worth searching for new potential antipsychotics among arylpiperazine alkyl derivatives of salicylamide.https://www.mdpi.com/1422-0067/23/24/15929antipsychotic-like activityanxiolytic-like effectD<sub>2</sub> receptor antagonist5-HT<sub>1A</sub> receptor antagonistarylpiperazine derivative of salicylamide
spellingShingle Elżbieta Żmudzka
Klaudia Lustyk
Monika Głuch-Lutwin
Barbara Mordyl
Alicja Zakrzewska-Sito
Paweł Mierzejewski
Jolanta Jaśkowska
Marcin Kołaczkowski
Jacek Sapa
Karolina Pytka
Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents
International Journal of Molecular Sciences
antipsychotic-like activity
anxiolytic-like effect
D<sub>2</sub> receptor antagonist
5-HT<sub>1A</sub> receptor antagonist
arylpiperazine derivative of salicylamide
title Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents
title_full Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents
title_fullStr Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents
title_full_unstemmed Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents
title_short Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents
title_sort antipsychotic and anxiolytic like properties of a multimodal compound jjgw08 in rodents
topic antipsychotic-like activity
anxiolytic-like effect
D<sub>2</sub> receptor antagonist
5-HT<sub>1A</sub> receptor antagonist
arylpiperazine derivative of salicylamide
url https://www.mdpi.com/1422-0067/23/24/15929
work_keys_str_mv AT elzbietazmudzka antipsychoticandanxiolyticlikepropertiesofamultimodalcompoundjjgw08inrodents
AT klaudialustyk antipsychoticandanxiolyticlikepropertiesofamultimodalcompoundjjgw08inrodents
AT monikagłuchlutwin antipsychoticandanxiolyticlikepropertiesofamultimodalcompoundjjgw08inrodents
AT barbaramordyl antipsychoticandanxiolyticlikepropertiesofamultimodalcompoundjjgw08inrodents
AT alicjazakrzewskasito antipsychoticandanxiolyticlikepropertiesofamultimodalcompoundjjgw08inrodents
AT pawełmierzejewski antipsychoticandanxiolyticlikepropertiesofamultimodalcompoundjjgw08inrodents
AT jolantajaskowska antipsychoticandanxiolyticlikepropertiesofamultimodalcompoundjjgw08inrodents
AT marcinkołaczkowski antipsychoticandanxiolyticlikepropertiesofamultimodalcompoundjjgw08inrodents
AT jaceksapa antipsychoticandanxiolyticlikepropertiesofamultimodalcompoundjjgw08inrodents
AT karolinapytka antipsychoticandanxiolyticlikepropertiesofamultimodalcompoundjjgw08inrodents